Curis, Inc.

CRIS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Revenue $9.9M $7.5M $7.9M $9.8M $15.0M $17.0M $14.8M $16.0M
Cost of Revenue — — — — — — — —
Gross Profit — — — — — — — —
Gross Margin — — — — — — — —
Operating Expenses
Research & Development — $18.0M — $13.7M $12.9M $15.5M $13.7M $11.4M
SG&A Expense $14.1M $15.6M $12.9M $11.7M $11.3M $10.4M $8.3M $10.3M
Operating Income $-49.8M $-58.0M $-56.5M $-15.9M $-9.4M $-18.6M $-7.2M $-5.6M
Operating Margin -502.7% -771.1% -716.9% -161.2% -62.8% -109.7% -48.8% -35.2%
Interest Expense $4.0M $2.8M $3.3M $3.7M $3.8M $204.2K — —
Pretax Income — — — — — — — —
Income Tax Expense — — — — — — — —
Net Income $-53.3M $-60.4M $-59.0M $-18.7M $-12.3M $-16.4M $-9.9M $-4.4M
Net Margin -538.7% -802.6% -748.7% -190.3% -82.1% -96.7% -66.8% -27.7%
EPS (Basic) $-0.90 $-0.23 $-0.24 $-0.11 $-0.08 $-0.11 $-0.07 $-0.03
EPS (Diluted) $-0.90 $-0.23 $-0.24 $-0.11 $-0.08 $-0.11 $-0.07 $-0.03
Shares Outstanding (Basic) 65.7M 282.2M 258.0M 172.1M 171.7M 160.0M 154.2M 151.5M
Shares Outstanding (Diluted) 65.7M 282.2M 258.0M 172.1M 171.7M 160.0M 154.2M 151.5M
Dividends Per Share — — — — — — — —
← Newer Page 2 of 3 Older →